Expression of Kinase-defective Mutants of c-Src in Human Metastatic Colon Cancer Cells Decreases Bcl-xL and Increases Oxaliplatin- and Fas-induced Apoptosis
Open Access
- 1 October 2004
- journal article
- Published by Elsevier BV
- Vol. 279 (44), 46113-46121
- https://doi.org/10.1074/jbc.m408550200
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathwaysOncogene, 2003
- Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic ProgressionCell, 2002
- v-SRC'S hold over actin and cell adhesionsNature Reviews Molecular Cell Biology, 2002
- Apoptosis and cancer chemotherapyTrends in Cell Biology, 2001
- Apoptosis and cancer chemotherapyTrends in Cell Biology, 2001
- Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase AktOncogene, 2000
- The Hallmarks of CancerCell, 2000
- STAT-1-Independent Upregulation of FADD and Procaspase-3 and -8 in Cancer Cells Treated with Cytotoxic DrugsBiochemical and Biophysical Research Communications, 1999
- Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposideOncogene, 1997
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor: STUDY OF Lck- AND FynT-DEPENDENT T CELL ACTIVATIONJournal of Biological Chemistry, 1996